Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Arcadia Biosciences (RKDA) over the last 12 years, with Q1 2025 value amounting to $1.0 million.

  • Arcadia Biosciences' Other Non-Current Liabilities fell 5000.0% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.0 million, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $2.0 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q1 2025, Arcadia Biosciences' Other Non-Current Liabilities is $1.0 million, which was down 5000.0% from $2.0 million recorded in Q4 2024.
  • Over the past 5 years, Arcadia Biosciences' Other Non-Current Liabilities peaked at $2.1 million during Q1 2021, and registered a low of $1.0 million during Q1 2025.
  • Over the past 5 years, Arcadia Biosciences' median Other Non-Current Liabilities value was $2.0 million (recorded in 2022), while the average stood at $2.0 million.
  • As far as peak fluctuations go, Arcadia Biosciences' Other Non-Current Liabilities skyrocketed by 700.0% in 2021, and later plummeted by 5000.0% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Other Non-Current Liabilities stood at $2.1 million in 2021, then dropped by 3.38% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then tumbled by 50.0% to $1.0 million in 2025.
  • Its Other Non-Current Liabilities stands at $1.0 million for Q1 2025, versus $2.0 million for Q4 2024 and $2.0 million for Q3 2024.